A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer

Authors

B. Nervi, Washington University School of Medicine in St. Louis
A. Denes, Washington University School of Medicine in St. Louis
M. J. Ellis, Washington University School of Medicine in St. LouisFollow

Journal

Breast Cancer Online

Publication Date

2006

Volume

9

Issue

1

Inclusive Pages

e2

Document Type

Open Access Publication

DOI

10.1017/S1470903106004159

Rights and Permissions

B. Nervi, A. Denes and M. J. Ellis (2006). A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer. Breast Cancer Online, 9, e2 doi:10.1017/S1470903106004159. Copyright © 2006 Cambridge University Press. http://journals.cambridge.org

Recommended Citation

Nervi, B.; Denes, A.; and Ellis, M. J., "A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer." Breast Cancer Online. 9, 1. e2. (2006).
https://digitalcommons.wustl.edu/open_access_pubs/3229